![Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial - Journal of ... Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial - Journal of ...](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8cba6501-17ea-4f45-83f9-3921c0ea5b7c/gr1_lrg.jpg)
Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial - Journal of ...
![Mechanism of action of cholesterol lowering with bempedoic acid versus... | Download Scientific Diagram Mechanism of action of cholesterol lowering with bempedoic acid versus... | Download Scientific Diagram](https://www.researchgate.net/publication/343835890/figure/fig1/AS:936270410817536@1600235669125/Mechanism-of-action-of-cholesterol-lowering-with-bempedoic-acid-versus-statins.png)
Mechanism of action of cholesterol lowering with bempedoic acid versus... | Download Scientific Diagram
![New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? - ScienceDirect New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0021915020315872-gr1.jpg)
New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? - ScienceDirect
![New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4 - ScienceDirect New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109721002497-fx1.jpg)
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4 - ScienceDirect
![A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia | SpringerLink A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40256-020-00399-w/MediaObjects/40256_2020_399_Fig1_HTML.png)
A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia | SpringerLink
![Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr−/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid | Arteriosclerosis, Thrombosis, and Vascular Biology Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr−/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/69a13611-9ad9-41bd-95af-2460cc829c83/10ga1.jpg)
Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr−/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid | Arteriosclerosis, Thrombosis, and Vascular Biology
Efficacy and Safety of Bempedoic Acid Added to Maximally Tolerated Statins in Patients with Hypercholesterolemia and High Cardio
![CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins? | Journal of the American Heart Association CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins? | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/bd0e93fc-0e9f-4d99-a5ce-14f0da00c615/jah34014-fig-0001.png)
CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins? | Journal of the American Heart Association
![Phase Three Clinical Trials Shows That Bempedoic Acid Significantly Reduces LDL-Cholesterol And Also Haemoglobin A1c - Thailand Medical News Phase Three Clinical Trials Shows That Bempedoic Acid Significantly Reduces LDL-Cholesterol And Also Haemoglobin A1c - Thailand Medical News](https://www.thailandmedical.news/uploads/editor/files/Bempedoic%20acid.png)